The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug, how many beneficiaries used the drug, the cost per unit and the change in price from the prior year. Today’s update adds new fields, including the Average Sales Price, the number of manufacturers producing the drug, and what the drug is used to treat. This information is now available for all covered Part B and D drugs. The 2016 data show double-digit increases in spending per unit (i.e., price) for 876 Part D drugs and 145 Part B drugs, with 31 drugs increasing by more than 100%. CMS also released updated data on the prescription drugs prescribed by individual physicians and other providers paid under Medicare Part D.

Related News Articles

Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…
Perspective
Public
More than 34.1 million Americans were enrolled in a Medicare Advantage plan in 2025, accounting for 54% of all Medicare beneficiaries. We have seen enrollment…
Headline
The Centers for Medicare & Medicaid Services Feb. 2 updated guidance originally issued in September on a budget reconciliation bill …
Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based provider tax, as authorized under…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…